重新分类急性呼吸窘迫综合征
研究在PaO2/FiO2 150 mm Hg阈值下将中度ARDS分为轻中度与中重度两组,并分析严重ARDS按FiO2 80%分组的差异;结果显示150 mm Hg阈值使亚组分布更均匀,ECMO治疗患者多属高FiO2亚组。
要点
- 150 mm Hg的P/F阈值可将中度ARDS分为解剖生理特征更均匀的轻中度与中重度亚组。
- 严重ARDS中75%属高FiO2亚组,ECMO治疗者几乎90%属该亚组。
- 高FiO2亚组中接受ECMO者PaCO2及肺重量、非充气组织更高。
核心结论
- 以150 mm Hg为P/F阈值可更均匀地划分ARDS严重度亚组,并识别出解剖与生理特征不同的两类人群。
- 接受ECMO治疗的患者均属严重ARDS组,其中近90%属于高FiO2亚组。
研究设计与样本
- 在150 mm Hg P/F阈值下将中度ARDS患者分为轻中度(n=50)与中重度(n=55)两组。
- 将严重ARDS患者(3例FiO2缺失)按80% FiO2阈值分为高FiO2组(n=63)与低FiO2组(n=18)。
主要发现
- 与轻中度ARDS相比,中重度ARDS患者峰压、PaCO2和pH更高,肺更重、不均匀性更大、非充气组织更多、肺可复张性更大。
- 84例严重ARDS(P/F<100 mm Hg)中75%属高FiO2亚组,该亚组与低FiO2亚组仅PaCO2和肺重量不同。
关键数值与推荐
- 中度ARDS范围100-200 mm Hg,以150 mm Hg为阈值划分轻中度与中重度。
- 严重ARDS定义为P/F<100 mm Hg,以FiO2 80%为阈值划分高FiO2与低FiO2亚组。
临床怎么用
- 临床可考虑在中度ARDS中以150 mm Hg P/F阈值细分亚组,以识别解剖生理特征更重的患者。
- 严重ARDS中高FiO2亚组患者PaCO2及肺重量更高,可能更多需要ECMO评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: The ratio of PaO2 to FiO2 (P/F) defines acute respiratory distress syndrome (ARDS) severity and suggests appropriate therapies. OBJECTIVES: We investigated 1) whether a 150-mm-Hg P/F threshold within the range of moderate ARDS (100-200 mm Hg) would define two subgroups that were more homogeneous; and 2) which criteria led the clinicians to apply extracorporeal membrane oxygenation (ECMO) in severe ARDS. METHODS: At the 150-mm-Hg P/F threshold, moderate patients were split into mild-moderate (n = 50) and moderate-severe (n = 55) groups. Patients with severe ARDS (FiO2 not available in three patients) were split into higher (n = 63) and lower (n = 18) FiO2 groups at an 80% FiO2 threshold. MEASUREMENTS AND MAIN RESULTS: Compared with mild-moderate ARDS, patients with moderate-severe ARDS had higher peak pressures, PaCO2, and pH. They also had heavier lungs, greater inhomogeneity, more noninflated tissue, and greater lung recruitability. Within 84 patients with severe ARDS (P/F < 100 mm Hg), 75% belonged to the higher FiO2 subgroup. They differed from the patients with severe ARDS with lower FiO2 only in PaCO2 and lung weight. Forty-one of 46 patients treated with ECMO belonged to the higher FiO2 group. Within this group, the patients receiving ECMO had higher PaCO2 than the 22 non-ECMO patients. The inhomogeneity ratio, total lung weight, and noninflated tissue were also significantly higher. CONCLUSIONS: Using the 150-mm-Hg P/F threshold gave a more homogeneous distribution of patients with ARDS across the severity subgroups and identified two populations that differed in their anatomical and physiological characteristics. The patients treated with ECMO belonged to the severe ARDS group, and almost 90% of them belonged to the higher FiO2 subgroup.
引用
- Maiolo G, Collino F, Vasques F, et al. Reclassifying Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2018. PMID: 29345967. doi:10.1164/rccm.201709-1804OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。